Trial · NCT07882797
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in joint angle distributions during standardized movement tasks | Baseline (V1), Month 6 (V2), Month 12 (V3) | Change in joint angle distributions across predefined joints and standardized movement tasks from baseline to 6 and 12 months. Joint angle distributions will be characterized using prespecified parameters describing joint kinematics. Changes in these parameters will be assessed at each follow-up visit relative to baseline. |
| Primary | Change in movement velocity | Baseline (V1), Month 6 (V2), Month 12 (V3) | Quantitative assessment of joint and limb movement velocities during standardized motor tasks |
| Primary | Change in movement-space volume | Baseline (V1), Month 6 (V2), Month 12 (V3) | Quantification of the three-dimensional movement space achieved by individual joints or body segments during standardized movement tasks |
| Primary | Change in coordination patterns | Baseline (V1), Month 6 (V2), Month 12 (V3) | Quantitative assessment of intersegmental and inter-joint coordination during standardized movements |
| Primary | Change in side-to-side movement symmetry | Baseline (V1), Month 6 (V2), Month 12 (V3) | Quantification of asymmetries between the left and right sides during standardized upper- and lower-limb movements |
| Primary | Change in proximal versus distal movement patterns | Baseline (V1), Month 6 (V2), Month 12 (V3) | Quantification of differences in movement characteristics between proximal and distal joints and body segments |
| Primary | Change in upper- versus lower-limb movement patterns | Baseline (V1), Month 6 (V2), Month 12 (V3) | Quantification of differences in movement characteristics between upper and lower extremities |
| Primary | Change in whole-body movement fingerprint | Baseline (V1), Month 6 (V2), Month 12 (V3) | Longitudinal change in the multidimensional sensor-derived movement fingerprint |
| Primary | Correlation between sensor-derived joint angle distributions and the I-RODS score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived joint angle distributions and activity and participation limitations assessed using the 24-item Inflammatory Rasch-built Overall Disability Scale (I-RODS). The I-RODS total score ranges from 0 to 48, with higher scores indicating better function. |
| Primary | Correlation between sensor-derived movement velocity and the I-RODS score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived movement velocity and activity and participation limitations assessed using the 24-item Inflammatory Rasch-built Overall Disability Scale (I-RODS). The I-RODS total score ranges from 0 to 48, with higher scores indicating better function. |
| Primary | Correlation between sensor-derived whole-body movement fingerprint and the I-RODS score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived whole-body movement fingerprint and activity and participation limitations assessed using the 24-item Inflammatory Rasch-built Overall Disability Scale (I-RODS). The I-RODS total score ranges from 0 to 48, with higher scores indicating better function. |
| Primary | Correlation between sensor-derived joint angle distributions and the INCAT disability score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived joint angle distributions and disability assessed using the Inflammatory Neuropathy Cause and Treatment (INCAT) disability scale. The INCAT total score ranges from 0 to 10, with lower scores indicating less disability and higher scores indicating greater disability. |
| Primary | Correlation between sensor-derived movement velocity and the INCAT disability score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived movement velocity and disability assessed using the Inflammatory Neuropathy Cause and Treatment (INCAT) disability scale. The INCAT total score ranges from 0 to 10, with lower scores indicating less disability and higher scores indicating greater disability. |
| Primary | Correlation between sensor-derived whole-body movement fingerprint and the INCAT disability score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived whole-body movement fingerprint and disability assessed using the Inflammatory Neuropathy Cause and Treatment (INCAT) disability scale. The INCAT total score ranges from 0 to 10, with lower scores indicating less disability and higher scores indicating greater disability. |
| Primary | Correlation between sensor-derived joint angle distributions and the MRC sum score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived joint angle distributions and muscle strength assessed using the Medical Research Council (MRC) sum score. The MRC sum score ranges from 0 to 60, with higher scores indicating greater muscle strength. |
| Primary | Correlation between sensor-derived movement velocity and the MRC sum score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived movement velocity and muscle strength assessed using the Medical Research Council (MRC) sum score. The MRC sum score ranges from 0 to 60, with higher scores indicating greater muscle strength. |
| Primary | Correlation between sensor-derived whole-body movement fingerprint and the MRC sum score | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived whole-body movement fingerprint and muscle strength assessed using the Medical Research Council (MRC) sum score. The MRC sum score ranges from 0 to 60, with higher scores indicating greater muscle strength. |
| Primary | Correlation between sensor-derived joint angle distributions and handgrip strength | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived joint angle distributions and handgrip strength assessed using a Martin Vigorimeter. Handgrip strength is expressed in kilopascals (kPa), according to the standardized measurement protocol. |
| Primary | Correlation between sensor-derived movement velocity and handgrip strength | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived movement velocity and handgrip strength assessed using a Martin Vigorimeter. Handgrip strength is expressed in kilopascals (kPa), according to the standardized measurement protocol. |
| Primary | Correlation between sensor-derived whole-body movement fingerprint and handgrip strength | Baseline (V1), Month 6 (V2), Month 12 (V3) | Correlation between sensor-derived whole-body movement fingerprint and handgrip strength assessed using a Martin Vigorimeter. Handgrip strength is expressed in kilopascals (kPa), according to the standardized measurement protocol. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07882797/registered